Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 30, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled critical new insights into the biological underpinnings of depression, identifying two distinct types of brain cells…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 23, 2026 Rebecca Shoemaker Montreal, QC – In a significant advancement for understanding one of the world’s most pervasive mental health conditions, researchers at McGill University and the Douglas Institute have identified distinct functional…
Psychology & Intimacy Parkinson’s Disease Stem Cell Therapy Trial at Keck Medicine of USC Offers Hope for Dopamine Restoration April 23, 2026 Rebecca Shoemaker Parkinson’s disease, a progressive and debilitating neurological disorder, continues to present a significant public health challenge in the United States. Affecting over one million individuals nationwide, with approximately 90,000 new…
Psychology & Intimacy Advancing Parkinson’s Treatment: Keck Medicine of USC Pioneers Stem Cell Therapy to Restore Dopamine Production April 15, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless neurodegenerative disorder, impacts the lives of over one million individuals in the United States, with approximately 90,000 new diagnoses occurring annually. Characterized by its progressive nature,…
Psychology & Intimacy A Groundbreaking Stem Cell Therapy Offers New Hope in the Fight Against Parkinson’s Disease April 6, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless and progressive neurodegenerative disorder, casts a long shadow over the lives of over one million individuals in the United States. Each year, approximately 90,000 new diagnoses…
Psychology & Intimacy Parkinson’s Disease Research Advances with Novel Stem Cell Therapy in Early Clinical Trials March 28, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless and progressive neurological disorder affecting millions worldwide, is now the subject of a groundbreaking clinical trial exploring a novel stem cell therapy designed to directly address…
Psychology & Intimacy Keck Medicine of USC Investigates Groundbreaking Stem Cell Therapy for Parkinson’s Disease March 27, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless neurodegenerative disorder, casts a long shadow over the lives of over one million Americans. Each year, approximately 90,000 new diagnoses are added to this somber statistic,…
Psychology & Intimacy A Groundbreaking Stem Cell Therapy Offers New Hope for Parkinson’s Disease Patients March 21, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless neurodegenerative disorder, casts a long shadow over the lives of millions globally. In the United States alone, over one million individuals are grappling with its progressive…
